In a momentous gathering at ZAS, divisional heads came together for an inspiring ‘Towards Tomorrow – A Collective Visioning Session.’ Led by the Chairman and Managing Director, alongside visionary leaders, the event marked a pivotal occasion as the course for future goals was charted. With a shared vision to redefine success and innovation, the leaders set the tone for an impactful year ahead, aiming to propel ZAS toward unprecedented heights. The collaborative efforts of the divisional heads promise a year of transformative growth and innovation for the company.
More Releases

ZAS Onco & MOSB Host Scientific Seminar on Recent Advances in Bevacizumab Therapy
ZAS Onco, a division of ZAS Corporation Ltd., in collaboration with the Medical Oncology Society of Bangladesh...
|
03 Jun, 2025

ZAS Corporation Joins Aqvida GmbH in Celebrating 20 Years of Oncology Excellence in Germany
Hamburg & Dassow, Germany | 14–17 May 2025ZAS Corporation proudly participated in the 20th anniversary...
|
22 May, 2025

ZAS Corporation and Canyon Introduce Microwave Ablation for Fibroids for the First Time in Bangladesh
In a groundbreaking advancement for women’s healthcare in Bangladesh, ZAS Corporation, in collaboration...
|
08 May, 2025

ZAS Ophthalmic Successfully Launches Timo-COMOD and Pollival with Leading Ophthalmologists
ZAS Ophthalmic, a concern of ZAS Group, proudly launched two innovative ophthalmic products — Timo-COMOD...
|
29 Apr, 2025

Round Table Discussion on Preventing Recurrent RTIs in Children
Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians,...
|
13 Jan, 2025

ZAS Corporation Ltd. Signs MOU with The Ibn Sina Trust to Enhance Employee Healthcare Access
ZAS Corporation Ltd. is proud to announce the signing of a Memorandum of Understanding (MOU) with The...
|
12 Dec, 2024

Rise & Refresh: ZAS Corporation’s Inspiring Year-End Retreat to Kuakata
ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque...
|
12 Dec, 2024

ZAS Corporation Ltd. Partners with LABAID Diagnostics and LABAID Cancer Hospital for Employee Healthcare
ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with...
|
12 Dec, 2024

ZAS Corporation Introduces Uro-Vaxom to Bangladesh: A Milestone in UTI Prevention
ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland,...
|
21 Nov, 2024

ZAS Corporation Hosts Virtual CME on Kidney Transplant Induction Therapy
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology...
|
04 Nov, 2024